A UiB-study shows that the taking of diabetes medicine reduces the risk of getting Parkinson´s disease.
Researchers at the Department of Clinical Medicine at the University of Bergen (UiB) have discovered that medical treatment against diabetes reduces the risk of getting Parkinson´s disease by 35 per cent.
“We have made an important discovery, which takes us a step further towards solving the Parkinson´s riddle,” says researcher Charalampos Tzoulis. He has lead the study together with researcher Kristoffer Haugarvoll at the same department.
One step further
Tzoulis says that the researchers have to do follow-up studies on the diabetes medicine to fully understand why it protects against Parkinson´s disease.
“If we understand the mechanisms behind the protection, then we have a chance to develop a new treatment,” Tzoulis says.
The study is published in the journal Movement Disorders.
Influence the cell´s powerhouse
The researchers believe that the diabetes medicines, containing so-called glitazones, are influencing the cells to produce more mitochondria. Mitochondria are the powerhouse of the cells, transforming nutrients that the cells need to work.
Tzoulis´research group has previously shown that the production of mitochondria decreases during Parkinson´s.
100 million prescriptions
To see the connection between diabetes and Parkinson´s, the researchers analysed and compared data from the Norwegian Prescription Data Base. The database has stored information on all use of prescription the last 10 years and contains data on more than 100 million prescriptions.
Learn more: Diabetes medicine reduces Parkinson’s risk
The Latest on: Parkinson´s disease
- Development Strategies for Parkinson's Disease Therapeutics Market 2026 - Global Research by Applications and Regionson October 17, 2019 at 9:57 am
Seattle, WA -- (SBWIRE) -- 10/17/2019 -- Parkinson's disease (PD) is a chronic disorder which leads to malfunctioning and death of vital nerve cells in the brain and can be caused by tremor, dementia, ...
- Tigard gym throws one-two punch at Parkinson’s diseaseon October 17, 2019 at 5:00 am
PORTLAND, Ore. (KOIN) — Parkinson’s patients are literally fighting the disease with the help of a boxing gym that recently expanded to a bigger space in Tigard. Kimberly Berg’s Rebel Fit Club offers ...
- New strategy to treat Parkinson's diseaseon October 17, 2019 at 12:24 am
Northwestern Medicine scientists have used patient-derived neurons to develop and test a new strategy to treat Parkinson's disease by mitigating the effects of harmful genetic mutations, as detailed ...
- Billy Connolly: I'm quite happy taking my Parkinson's disease medication and getting on with iton October 17, 2019 at 12:04 am
Billy Connolly said he is "quite happy" taking his medication and "getting on with it [life]", six years after being diagnosed with Parkinson’s disease. The 76-year-old actor and comedian recently ...
- 'It is not hopeless': Parkinson’s disease doesn't stop Austin duo from making popular arton October 16, 2019 at 9:04 am
That was the first sign. Later, she felt tremors on one side of her body. Ten years ago, she was diagnosed with Parkinson’s disease. That’s when she stopped painting. “I got tired,” Verna, 88, says.
- Bipolar disorder may increase risk for developing Parkinson diseaseon October 15, 2019 at 1:27 pm
(HealthDay)—Patients with bipolar disorder (BD) seem to have an increased risk for developing Parkinson disease (PD), according to a review published online Oct. 14 in JAMA Neurology. Patricia R.
- Global Parkinson's disease Drugs Market Trends, Analysis, Segmentation, and Forecast, to 2016-2022on October 15, 2019 at 5:02 am
Oct 15, 2019 (AmericaNewsHour) -- Parkinson's disease is a disorder of the Central Nervous System that affects the motor system. According to the report, XX number of people suffer from Parkinson's ...
- Global Parkinsons Disease Drugs Market Growth opportunities and Demand Forecast 2016-2022on October 15, 2019 at 5:02 am
Oct 15, 2019 (AmericaNewsHour) -- Parkinson's disease is a neurodegenerative disorder which affects the dopamine-producing neurons in a specific area of the brain called substantial nigra. It affects ...
- Neurobiology and Therapeutic Targets of Parkinson’s Diseaseon October 15, 2019 at 1:36 am
After Alzheimer’s Disease, the second most prevalent neurodegenerative disease is Parkinson or Parkinson’s Disease (PD). The diagnosis of this disease is based on the occurrence of bradykinesia, ...
- Study further suggests link between bipolar disorder, risk for Parkinson’s diseaseon October 14, 2019 at 12:03 pm
Patients with bipolar disorder appeared significantly more likely to develop Parkinson’s disease than the general population, according to results of a systematic review and meta-analysis published in ...
via Google News and Bing News